Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 15, 1998

View Archived Issues

Inex: Q3 1998 highlights

Sanofi-Synthelabo: poised to become number six in Europe

Next-generation SERM presented by Hoechst Marion Roussel

MAA for AcuTect temporarily withdrawn pending submission of additional information

AVI BioPharma reports encouraging clinical data from phase II Avicine study

Procept, Pacific Pharmaceuticals move closer to merger

Medarex reports setback in phase III trial of MDX-RA

Oxigene describes mechanism of action, therapeutic potential of declopramide

U.S. patent issues to Alexion, paving the way to improved xenotransplantation technology

Vanguard Medica takes on development of imiquimod analogue

First launch for Novartis anticoagulant takes place in Germany

Merckle launches new treatment for narcolepsy in Germany

Another market introduction for imiquimod

Anticoagulant cyclic diaza compounds reported by Cor Therapeutics

New antitumor compounds presented by Kyorin

Another merger agreement revealed: Corixa to acquire Anergen

New hemophilia treatment one step closer to market

New prostanoid compound from Ono is a useful tool for studying cardiovascular system

Novel glutamate receptor antagonist shows excellent potential as antiepileptic agent

Review of AIDSVAX studies past and present

Bayer and AxyS initiate development of oral asthma compound

Antipruritic, immunosuppressive MS-444 derivatives reported by Kyowa Hakko

Clinical studies support excellent safety and efficacy of Busulfex

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...